Drug Discovery Bioanalytical Solutions: Quick Turnarounds For Lead Optimization

Discovery bioanalysis plays a crucial role in providing rapid, fit-for-purpose, high-quality non-GLP bioanalytical data to evaluate the pharmacokinetic (PK) characteristics of potential drug candidates, all while minimizing time and cost during the early stages of drug discovery. Fast turnaround times in the laboratory are essential for achieving these objectives.

The Aliri team recognizes the importance of responsiveness and quick turnarounds in optimizing lead compounds for your drug development strategy. We offer the technical expertise, solutions, and high-quality data needed to efficiently navigate this critical phase with confidence.

Partnering with Aliri from the outset of your project allows for rapid turnaround times with data delivered in a consistent format, identification of options and opportunities to advance molecules, access to a broad range of matrices, and the flexibility to adapt to changing or accelerated timelines.